Welcome to BaseLaunch
We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures developing cutting-edge therapeutics. And we know how to do this – so far our portfolio has raised over $800M in financing with an average first VC round of over $28M per company.

Up to $500,000
in financing

Access to our partners,
global biopharma & investors

Company & team
build out
Access to labs &
related infrastructure
where needed
Latest news

Synendos Reports Positive Phase 1 Results for SYT-510, Preparing for Phase 2
Synendos Reports Positive Phase 1 Results for SYT-510, Preparing for Phase 2

metaLead Therapeutics Appoints David Urech as Member of the Board of Directors
metaLead Therapeutics Appoints David Urech as Member of the Board of Directors

Gibela publishes groundbreaking research in Hepatology
Gibela publishes groundbreaking research in Hepatology

Synendos Appoints Dr. George Garibaldi as Chief Medical Officer
Synendos Appoints Dr. George Garibaldi as Chief Medical Officer

We welcome BioDuro as our new domain partner
We welcome BioDuro as our new domain partner

Hemastatx joins BaseLaunch portfolio